Search research articles
Contact Us
Filters
Showing results (131-140 of 246) with videos related to
Page
of 25
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
January 24, 1998
Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease
R T Matthews, L Yang, B G Jenkins, et al.
Journal of Neurochemistry
|
November 19, 2003
Sequential activation of individual caspases, and of alterations in Bcl-2 proapoptotic signals in a mouse model of Huntington's disease
Yu Zhang, Victor O Ona, Mingwei Li, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 7, 2002
Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease
Robert J Ferrante, Ole A Andreassen, Alpaslan Dedeoglu, et al.
Annals of the New York Academy of Sciences
|
January 1, 1989
Calcium channels in smooth muscle. Properties and regulation
D J Triggle, W Zheng, M Hawthorn, et al.
Annals of Neurology
|
April 13, 2000
Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis
O A Andreassen, R J Ferrante, P Klivenyi, et al.
European Journal of Immunology
|
July 1, 1996
Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response
F Mattner, J Magram, J Ferrante, et al.
Neuromolecular Medicine
|
July 4, 2002
Cytochrome C and caspase-9 expression in Huntington's disease
Tamara Kiechle, Alpaslan Dedeoglu, James Kubilus, et al.
Journal of Medicinal Chemistry
|
March 8, 2011
Pyrimidine-2,4,6-trione derivatives and their inhibition of mutant SOD1-dependent protein aggregation. Toward a treatment for amyotrophic lateral sclerosis
Guoyao Xia, Radhia Benmohamed, Jinho Kim, et al.
Experimental Neurology
|
May 1, 1999
Creatine and cyclocreatine attenuate MPTP neurotoxicity
R T Matthews, R J Ferrante, P Klivenyi, et al.
European Urology
|
September 23, 2019
Androgen Receptor Modulation Optimized for Response-Splice Variant: A Phase 3, Randomized Trial of Galeterone Versus Enzalutamide in Androgen Receptor Splice Variant-7-expressing Metastatic Castration-resistant Prostate Cancer
Mary-Ellen Taplin, Emmanuel S Antonarakis, Karen J Ferrante, et al.
Page
of 25
Search research articles
Search
Showing results (131-140 of 246) with videos related to
Sort By:
Page
of 25
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
January 24, 1998
Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease
R T Matthews, L Yang, B G Jenkins, et al.
Journal of Neurochemistry
|
November 19, 2003
Sequential activation of individual caspases, and of alterations in Bcl-2 proapoptotic signals in a mouse model of Huntington's disease
Yu Zhang, Victor O Ona, Mingwei Li, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 7, 2002
Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease
Robert J Ferrante, Ole A Andreassen, Alpaslan Dedeoglu, et al.
Annals of the New York Academy of Sciences
|
January 1, 1989
Calcium channels in smooth muscle. Properties and regulation
D J Triggle, W Zheng, M Hawthorn, et al.
Annals of Neurology
|
April 13, 2000
Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis
O A Andreassen, R J Ferrante, P Klivenyi, et al.
European Journal of Immunology
|
July 1, 1996
Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response
F Mattner, J Magram, J Ferrante, et al.
Neuromolecular Medicine
|
July 4, 2002
Cytochrome C and caspase-9 expression in Huntington's disease
Tamara Kiechle, Alpaslan Dedeoglu, James Kubilus, et al.
Journal of Medicinal Chemistry
|
March 8, 2011
Pyrimidine-2,4,6-trione derivatives and their inhibition of mutant SOD1-dependent protein aggregation. Toward a treatment for amyotrophic lateral sclerosis
Guoyao Xia, Radhia Benmohamed, Jinho Kim, et al.
Experimental Neurology
|
May 1, 1999
Creatine and cyclocreatine attenuate MPTP neurotoxicity
R T Matthews, R J Ferrante, P Klivenyi, et al.
European Urology
|
September 23, 2019
Androgen Receptor Modulation Optimized for Response-Splice Variant: A Phase 3, Randomized Trial of Galeterone Versus Enzalutamide in Androgen Receptor Splice Variant-7-expressing Metastatic Castration-resistant Prostate Cancer
Mary-Ellen Taplin, Emmanuel S Antonarakis, Karen J Ferrante, et al.
Page
of 25